Literature DB >> 32947381

Timing of Fluid Overload and Association With Patient Outcome.

Lisa Lima1, Shina Menon2,3, Stuart L Goldstein2,4, Rajit K Basu1.   

Abstract

OBJECTIVES: To determine if the timing of excess fluid accumulation (fluid overload) is associated with adverse patient outcomes.
DESIGN: Secondary analysis of a prospectively collected dataset.
SETTING: PICU of a tertiary care hospital. PATIENTS: Children 3 months to 25 years old admitted to the PICU with expected length of stay greater than or equal to 48 hours.
INTERVENTIONS: Patients were dichotomized by time of peak overload: peak fluid overload from ICU admission (Day0) to 48 hours (Day3-7) and peak fluid overload value after 48 hours of ICU admission, as well as time of first-time negative daily fluid balance: net fluid out greater than net fluid in for that 24-hour period.
MEASUREMENTS AND MAIN RESULTS: There were 177 patients who met inclusion criteria, 92 (52%) male, with an overall mortality rate of 7% (n = 12). There were no differences in severity of illness scores or fluid overload on Day0 between peak fluid overload from ICU admission (Day0) to 48 hours (Day3-7) (n = 97; 55%) and peak fluid overload value after 48 hours of ICU admission (n = 80; 45%) groups. Peak fluid overload value after 48 hours of ICU admission was associated with a longer median ICU course (8 [4-15] vs 4 d [3-8 d]; p ≤ 0.001], hospital length of stay (18 [10-38) vs 12 [8-24]; p = 0.01], and increased risk of mortality (n = 10 [13%] vs 2 [2%]; χ2 = 7.6; p = 0.006]. ICU length of stay was also longer in the peak fluid overload value after 48 hours of ICU admission group when only patients with at least 7 days of ICU stay were analyzed (p = 0.02). Timing of negative fluid balance was also correlated with outcome. Compared with Day0-2, a negative daily fluid balance on Day3-7 was associated with increased length of mechanical ventilation (3 [1-7] vs 1 d [2-10 d]; p ≤ 0.001) and increased hospital (17 [10-35] vs 11 d [7-26 d]; p = 0.006) and ICU (7 [4-13] vs 4 d [3-7 d]; p ≤ 0.001) length of stay compared with a negative fluid balance between Day0-2.
CONCLUSIONS: Our results show timing of fluid accumulation not just peak percentage accumulated is associated with patient outcome. Further exploration of the association between time and fluid accumulation is warranted.
Copyright © 2020 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Entities:  

Year:  2021        PMID: 32947381     DOI: 10.1097/PCC.0000000000002547

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

Review 1.  Neonatal fluid overload-ignorance is no longer bliss.

Authors:  Lucinda J Weaver; Colm P Travers; Namasivayam Ambalavanan; David Askenazi
Journal:  Pediatr Nephrol       Date:  2022-03-29       Impact factor: 3.714

2.  Questions About Fluid Management in Pediatric Acute Respiratory Distress Syndrome and the Design of Clinical Trials.

Authors:  Anoopindar Bhalla; Robinder G Khemani
Journal:  Pediatr Crit Care Med       Date:  2021-09-01       Impact factor: 3.971

3.  Timing and Clinical Significance of Fluid Overload in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Celeste G Black; Neal J Thomas; Nadir Yehya
Journal:  Pediatr Crit Care Med       Date:  2021-09-01       Impact factor: 3.971

4.  Renal angina index predicts fluid overload in critically ill children: an observational cohort study.

Authors:  Stephen M Gorga; Erin F Carlton; Joseph G Kohne; Ryan P Barbaro; Rajit K Basu
Journal:  BMC Nephrol       Date:  2021-10-11       Impact factor: 2.388

5.  Early Cumulative Fluid Balance and Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients With Acute Respiratory Failure: A Multicenter Study.

Authors:  Colin J Sallee; Lincoln S Smith; Courtney M Rowan; Susan R Heckbert; Joseph R Angelo; Megan C Daniel; Shira J Gertz; Deyin D Hsing; Kris M Mahadeo; Jennifer A McArthur; Julie C Fitzgerald
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.